Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Sravanthi Rai"'
Autor:
Shashank Chetty, Reza Yarani, Ganesh Swaminathan, Rosita Primavera, Shobha Regmi, Sravanthi Rai, Jim Zhong, Abantika Ganguly, Avnesh S Thakor
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 10 (2022)
In recent years, mesenchymal stromal cells (MSCs) have generated a lot of attention due to their paracrine and immuno-modulatory properties. mesenchymal stromal cells derived from the umbilical cord (UC) are becoming increasingly recognized as having
Externí odkaz:
https://doaj.org/article/4910bc5945334af486f0887b17c5778a
Publikováno v:
Stem Cell Research & Therapy, Vol 11, Iss 1, Pp 1-15 (2020)
Abstract Background Acute kidney injury (AKI) is characterized by rapid failure of renal function and has no curative therapies. Mesenchymal stromal cell (MSC)-derived extracellular vesicles (EVs) are known to carry therapeutic factors, which have sh
Externí odkaz:
https://doaj.org/article/47b4379e979e4ffea2fb30da82d398b2
Autor:
Mujib Ullah, Daniel D. Liu, Sravanthi Rai, Arya Dadhania, Sriya Jonnakuti, Waldo Concepcion, Avnesh S. Thakor
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 17, Iss , Pp 683-694 (2020)
Acute kidney injury (AKI) is characterized by a sudden failure of renal function, but despite increasing worldwide prevalence, current treatments are largely supportive, with no curative therapies. Mesenchymal stromal cell (MSC) therapy has been show
Externí odkaz:
https://doaj.org/article/8f9b545d422f4ac29a22238c85b35658
Autor:
Mujib Ullah, Daniel D. Liu, Sravanthi Rai, Mehdi Razavi, Jeff Choi, Jing Wang, Waldo Concepcion, Avnesh S. Thakor
Publikováno v:
Cells, Vol 9, Iss 4, p 937 (2020)
Diseases of the kidney contribute a significant morbidity and mortality burden on society. Localized delivery of therapeutics directly into the kidney, via its arterial blood supply, has the potential to enhance their therapeutic efficacy while limit
Externí odkaz:
https://doaj.org/article/f58b85f4fb684615892cae1dcca7d6ac
Autor:
Waldo Concepcion, Sravanthi Rai, Daniel D. Liu, Avnesh S. Thakor, Sriya Jonnakuti, Mujib Ullah, Arya Dadhania
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 17, Iss, Pp 683-694 (2020)
Molecular Therapy. Methods & Clinical Development
Molecular Therapy. Methods & Clinical Development
Acute kidney injury (AKI) is characterized by a sudden failure of renal function, but despite increasing worldwide prevalence, current treatments are largely supportive, with no curative therapies. Mesenchymal stromal cell (MSC) therapy has been show
Publikováno v:
Stem Cell Research & Therapy
Stem Cell Research & Therapy, Vol 11, Iss 1, Pp 1-15 (2020)
Stem Cell Research & Therapy, Vol 11, Iss 1, Pp 1-15 (2020)
Background Acute kidney injury (AKI) is characterized by rapid failure of renal function and has no curative therapies. Mesenchymal stromal cell (MSC)-derived extracellular vesicles (EVs) are known to carry therapeutic factors, which have shown promi
Publikováno v:
International Journal of Molecular Sciences
Volume 21
Issue 11
International Journal of Molecular Sciences, Vol 21, Iss 4085, p 4085 (2020)
Volume 21
Issue 11
International Journal of Molecular Sciences, Vol 21, Iss 4085, p 4085 (2020)
Acute kidney injury (AKI) is the abrupt loss of renal function, for which only supportive therapies exist. Mesenchymal stromal cell (MSC)-derived extracellular vesicles (EVs) have been shown to be therapeutically effective in treating AKI by spurring
Autor:
Waldo Concepcion, Mehdi Razavi, Jing Wang, Mujib Ullah, Daniel D. Liu, Sravanthi Rai, Avnesh S. Thakor, Jeff Choi
Publikováno v:
Cells
Cells, Vol 9, Iss 937, p 937 (2020)
Cells, Vol 9, Iss 937, p 937 (2020)
Diseases of the kidney contribute a significant morbidity and mortality burden on society. Localized delivery of therapeutics directly into the kidney, via its arterial blood supply, has the potential to enhance their therapeutic efficacy while limit